Orano Med is a clinical-stage biotechnology company and subsidiary of the Orano group specializing in nuclear medicine. It develops lead-212-based targeted alpha therapies for cancer and is expanding manufacturing capacities for lead-212 radiolabeled pharmaceuticals in North America and Europe.
Investment Rounds
Capital activity and funding progression
Industries
Frequently Asked Questions
Where is Orano Med located?
Orano Med is located in Paris, France.
What industries does Orano Med operate in?
Orano Med operates in the following industries: biotechnology, nuclear medicine, cancer therapeutics.
Who are the investors in Orano Med?
The investors in Orano Med are: European Investment Bank.